What is the role of EGFR inhibitors in the treatment of thymoma?

Updated: Dec 03, 2018
  • Author: Kendrix J Evans, MD, MS; Chief Editor: John Geibel, MD, MSc, DSc, AGAF  more...
  • Print

Studies have investigated the molecular changes in thymomas. In one study, 10 out of 12 thymomas exhibited epidermal growth factor receptor (EGFR) expression. This information would be useful in selecting patients that may benefit from EGFR inhibitors as part of their treatment regimen. Other areas of investigation include apoptosis-related markers, such as p63, a member of the p53 family. This marker is expressed in virtually all thymomas. Further research pertaining to the biology of thymomas will allow more adequate approaches to treatment.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!